Jeffrey Scott Riley, CEO, Director at Theriva Biologics, holds 30.00K shares in Gain Therapeutics (Ticker: GANX), holds 10.40K shares in Theriva Biologics (Ticker: TOVX). Most recently, Jeffrey Scott Riley Bought ― shares of Gain Therapeutics on Apr 01, 2024 for an estimated value of 115.50K.
What is the percentage of profitable transactions made by Jeffrey Scott Riley?
The percentage of profitable transactions made by Jeffrey Scott Riley is ―.
What is the average return per transaction made by Jeffrey Scott Riley?
The average return per transaction made by Jeffrey Scott Riley is ―.
What stocks does Jeffrey Scott Riley hold?
Jeffrey Scott Riley holds: TOVX, GANX stocks.
What was Jeffrey Scott Riley’s latest transaction?
Jeffrey Scott Riley latest transaction was an Informative Buy of $115.50K.
What was Jeffrey Scott Riley's most profitable transaction?
Jeffrey Scott Riley’s most profitable transaction was an Informative Buy of GANX stock on April 1, 2024. The return on the trade was -42.10%.
What is Jeffrey Scott Riley's role in Theriva Biologics?
Jeffrey Scott Riley's role in Theriva Biologics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.